Hong Kong
· Delayed Price · Currency is HKD CSPC Pharmaceutical Group Statistics
Total Valuation
CSPC Pharmaceutical Group has a market cap or net worth of HKD 52.88 billion. The enterprise value is 43.13 billion.
| Market Cap | 52.88B |
| Enterprise Value | 43.13B |
Important Dates
The next estimated earnings date is Friday, March 21, 2025.
| Earnings Date | Mar 21, 2025 |
| Ex-Dividend Date | Oct 31, 2024 |
Share Statistics
CSPC Pharmaceutical Group has 11.60 billion shares outstanding. The number of shares has decreased by -0.68% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 11.60B |
| Shares Change (YoY) | -0.68% |
| Shares Change (QoQ) | -1.00% |
| Owned by Insiders (%) | 24.52% |
| Owned by Institutions (%) | 31.88% |
| Float | 8.00B |
Valuation Ratios
The trailing PE ratio is 9.43 and the forward PE ratio is 9.50. CSPC Pharmaceutical Group's PEG ratio is 1.07.
| PE Ratio | 9.43 |
| Forward PE | 9.50 |
| PS Ratio | 1.61 |
| PB Ratio | 1.40 |
| P/TBV Ratio | 1.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.07 |
Enterprise Valuation
| EV / Earnings | 7.55 |
| EV / Sales | 1.29 |
| EV / EBITDA | 5.24 |
| EV / EBIT | 6.19 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | n/a |
| Interest Coverage | 151.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 1.65M |
| Profits Per Employee | 281,366 |
| Employee Count | 23,500 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.98% in the last 52 weeks. The beta is 0.68, so CSPC Pharmaceutical Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | -35.98% |
| 50-Day Moving Average | 5.15 |
| 200-Day Moving Average | 5.86 |
| Relative Strength Index (RSI) | 30.35 |
| Average Volume (20 Days) | 75,736,561 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSPC Pharmaceutical Group had revenue of HKD 33.53 billion and earned 5.71 billion in profits. Earnings per share was 0.48.
| Revenue | 33.53B |
| Gross Profit | 23.67B |
| Operating Income | 7.08B |
| Pretax Income | 7.23B |
| Net Income | 5.71B |
| EBITDA | 8.15B |
| EBIT | 7.08B |
| Earnings Per Share (EPS) | 0.48 |
Balance Sheet
The company has 11.98 billion in cash and 430.72 million in debt, giving a net cash position of 11.55 billion or 1.00 per share.
| Cash & Cash Equivalents | 11.98B |
| Total Debt | 430.72M |
| Net Cash | 11.55B |
| Net Cash Per Share | 1.00 |
| Equity (Book Value) | 40.40B |
| Book Value Per Share | 3.26 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.59%, with operating and profit margins of 21.11% and 17.04%.
| Gross Margin | 70.59% |
| Operating Margin | 21.11% |
| Pretax Margin | 21.56% |
| Profit Margin | 17.04% |
| EBITDA Margin | 24.31% |
| EBIT Margin | 21.11% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 6.97%.
| Dividend Per Share | 0.32 |
| Dividend Yield | 6.97% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | 10 |
| Payout Ratio | n/a |
| Buyback Yield | 0.68% |
| Shareholder Yield | 7.66% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
The last stock split was on Invalid Date. It was a forward split with a ratio of 1.6.
| Last Split Date | Invalid Date |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |